Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Fly Intel: Wall Street's top stories for Monday » 16:45
03/01/21
03/01
16:45
03/01/21
16:45
JNJ

Johnson & Johnson

$159.34 /

+0.92 (+0.58%)

, XOM

Exxon Mobil

$56.40 /

+2.02 (+3.71%)

, OTRK

Ontrak

$31.62 /

-27.515 (-46.53%)

, ATNX

Athenex

$5.47 /

-6.715 (-55.11%)

, DKNG

DraftKings

$68.71 /

+7.24 (+11.78%)

, MORF

Morphic

$84.57 /

+48.64 (+135.37%)

The three major averages…

ShowHide Related Items >><<
XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

ATNX Athenex
$5.47 /

-6.715 (-55.11%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

02/26/21 Barclays
Exxon Mobil price target raised to $65 from $59 at Barclays
02/16/21 Credit Suisse
Exxon Mobil price target raised to $62 from $52 at Credit Suisse
02/08/21
Fly Intel: Top five analyst upgrades
02/08/21 Exane BNP Paribas
Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas
OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

03/01/21 RBC Capital
RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna
03/01/21 RBC Capital
Ontrak downgraded to Sector Perform from Outperform at RBC Capital
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
01/04/21 B. Riley Securities
Ontrak price target raised to $110 from $100 at B. Riley Securities
ATNX Athenex
$5.47 /

-6.715 (-55.11%)

03/01/21 JPMorgan
JPMorgan downgrades Athenex on 'huge surprise' from FDA
03/01/21 SVB Leerink
Athenex downgraded to Market Perform from Outperform at SVB Leerink
03/01/21 JPMorgan
Athenex downgraded to Neutral from Overweight at JPMorgan
03/01/21 Laidlaw
Athenex price target lowered to $13 from $38 at Laidlaw
DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

03/01/21 Craig-Hallum
DraftKings price target raised to $70 from $65 at Craig-Hallum
03/01/21 Canaccord
DraftKings price target raised to $80 from $65 at Canaccord
03/01/21 Northland
DraftKings price target raised to $70 from $55 at Northland
03/01/21 Benchmark
DraftKings price target raised to $69 from $66 at Benchmark
MORF Morphic
$84.57 /

+48.64 (+135.37%)

03/01/21 Wells Fargo
Morphic Holding price target raised to $103 from $40 at Wells Fargo
02/02/21 RBC Capital
Morphic Holding price target raised to $50 from $35 at RBC Capital
10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
08/11/20 BMO Capital
Morphic Holding price target raised to $37 from $30 at BMO Capital
XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

MORF Morphic
$84.57 /

+48.64 (+135.37%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

ATNX Athenex
$5.47 /

-6.715 (-55.11%)

  • 07
    Oct
  • 10
    Sep
  • 19
    Jun
XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

ATNX Athenex
$5.47 /

-6.715 (-55.11%)

XOM Exxon Mobil
$56.40 /

+2.02 (+3.71%)

OTRK Ontrak
$31.62 /

-27.515 (-46.53%)

JNJ Johnson & Johnson
$159.34 /

+0.92 (+0.58%)

DKNG DraftKings
$68.71 /

+7.24 (+11.78%)

Conference/Events
Cantor Fitzgerald biopharma analysts hold an analyst/industry conference call » 15:48
03/01/21
03/01
15:48
03/01/21
15:48
ADVM

Adverum Biotechnologies

$13.31 /

+0.455 (+3.54%)

, UBX

Unity Biotechnology

$7.53 /

+0.7 (+10.25%)

, AGTC

Applied Genetic

$5.64 /

+0.54 (+10.59%)

, JNJ

Johnson & Johnson

$159.50 /

+1.08 (+0.68%)

, MGTX

MeiraGTx

$15.21 /

+0.4 (+2.70%)

, NITE

Nightstar Therapeutics

$25.41 /

+ (+0.00%)

, BIIB

Biogen

$272.79 /

-0.16 (-0.06%)

, AERI

Aerie Pharmaceuticals

$19.36 /

+0.96 (+5.22%)

, ALDX

Aldeyra

$12.20 /

-0.05 (-0.41%)

Biopharmaceuticals…

Biopharmaceuticals Analyst Chen, along with Dr. Ruchita Amin, Retina Specialist at Retina Vitreous Associates and Dr. Roger Goldberg, Partner and Vitreoretinal Surgeon at Bay Area Retina Associates, discuss hot topics and key 2021 focus areas in eye diseases on an Analyst/Industry Conference Call to be held on March 8 at 1 pm.

ShowHide Related Items >><<
UBX Unity Biotechnology
$7.53 /

+0.7 (+10.25%)

MGTX MeiraGTx
$15.21 /

+0.4 (+2.70%)

JNJ Johnson & Johnson
$159.50 /

+1.08 (+0.68%)

BIIB Biogen
$272.79 /

-0.16 (-0.06%)

ALDX Aldeyra
$12.20 /

-0.05 (-0.41%)

AGTC Applied Genetic
$5.64 /

+0.54 (+10.59%)

AERI Aerie Pharmaceuticals
$19.36 /

+0.96 (+5.22%)

ADVM Adverum Biotechnologies
$13.31 /

+0.455 (+3.54%)

ADVM Adverum Biotechnologies
$13.31 /

+0.455 (+3.54%)

12/15/20 UBS
Adverum Biotechnologies initiated with a Neutral at UBS
11/15/20 Piper Sandler
Adverum Biotechnologies shares should grind higher over time, says Piper Sandler
11/12/20 Raymond James
Adverum Biotechnologies upgraded to Market Perform from Underperform at Raymond James
11/12/20 Raymond James
Adverum Biotechnologies upgraded to Market Perform at Raymond James
UBX Unity Biotechnology
$7.53 /

+0.7 (+10.25%)

02/16/21 Citi
Unity Biotechnology downgraded to Sell from Neutral at Citi
08/18/20
Fly Intel: Top five analyst downgrades
08/18/20 Morgan Stanley
Unity Biotechnology downgraded at Morgan Stanley as UBX101 doesn't meet endpoint
08/18/20 Citi
Unity Biotechnology downgraded to Neutral from Buy at Citi
AGTC Applied Genetic
$5.64 /

+0.54 (+10.59%)

02/02/21 H.C. Wainwright
Applied Genetic price target raised to $24 from $18 at H.C. Wainwright
02/01/21 Roth Capital
Applied Genetic price target raised to $35 from $30 at Roth Capital
11/17/20 Roth Capital
Applied Genetic price target raised to $30 from $26 at Roth Capital
11/11/20 H.C. Wainwright
Applied Genetic XLRP data 'continue to impress,' says H.C. Wainwright
JNJ Johnson & Johnson
$159.50 /

+1.08 (+0.68%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
MGTX MeiraGTx
$15.21 /

+0.4 (+2.70%)

02/16/21 Chardan
MeiraGTx called a Top Pick for 2021 at Chardan
12/17/20 Chardan
Chardan boosts MeiraGTx target to $55, say buy shares 'now'
12/17/20 Piper Sandler
Piper says MeiraGTx not getting credit for RIX gene therapy that 'clearly works'
10/22/20 RBC Capital
MeiraGTx initiated with an Outperform at RBC Capital
NITE Nightstar Therapeutics
$25.41 /

+ (+0.00%)

BIIB Biogen
$272.79 /

-0.16 (-0.06%)

02/17/21 Cantor Fitzgerald
Biogen price target lowered to $268 from $278 at Cantor Fitzgerald
02/08/21 Citi
Expert sees Biogen aducanumab approval 50/50 at best, says Citi
02/04/21 SVB Leerink
Biogen price target lowered to $380 from $430 at SVB Leerink
02/04/21 Credit Suisse
Biogen price target lowered to $338 from $350 at Credit Suisse
AERI Aerie Pharmaceuticals
$19.36 /

+0.96 (+5.22%)

11/09/20 H.C. Wainwright
Aerie Pharmaceuticals price target lowered to $29 from $31 at H.C. Wainwright
10/28/20 H.C. Wainwright
Aerie Pharmaceuticals $50M upfront should reduce overhang, says H.C. Wainwright
10/19/20 BofA
Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
10/19/20 BofA
Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
ALDX Aldeyra
$12.20 /

-0.05 (-0.41%)

02/08/21 H.C. Wainwright
Aldeyra initiated with a Buy at H.C. Wainwright
01/28/21 JonesTrading
Aldeyra assumed with a Buy at JonesTrading
01/08/21 Jefferies
Aldeyra could double if topline of TRANQUILITY study positive, says Jefferies
01/08/21 Citi
Aldeyra shares have 'plenty of upside' despite 26% rally, says Citi
UBX Unity Biotechnology
$7.53 /

+0.7 (+10.25%)

MGTX MeiraGTx
$15.21 /

+0.4 (+2.70%)

JNJ Johnson & Johnson
$159.50 /

+1.08 (+0.68%)

BIIB Biogen
$272.79 /

-0.16 (-0.06%)

ALDX Aldeyra
$12.20 /

-0.05 (-0.41%)

AGTC Applied Genetic
$5.64 /

+0.54 (+10.59%)

AERI Aerie Pharmaceuticals
$19.36 /

+0.96 (+5.22%)

ADVM Adverum Biotechnologies
$13.31 /

+0.455 (+3.54%)

  • 28
    Jan
  • 14
    Jan
  • 19
    Nov
  • 13
    Aug
JNJ Johnson & Johnson
$159.50 /

+1.08 (+0.68%)

BIIB Biogen
$272.79 /

-0.16 (-0.06%)

UBX Unity Biotechnology
$7.53 /

+0.7 (+10.25%)

JNJ Johnson & Johnson
$159.50 /

+1.08 (+0.68%)

BIIB Biogen
$272.79 /

-0.16 (-0.06%)

ALDX Aldeyra
$12.20 /

-0.05 (-0.41%)

AGTC Applied Genetic
$5.64 /

+0.54 (+10.59%)

AERI Aerie Pharmaceuticals
$19.36 /

+0.96 (+5.22%)

BIIB Biogen
$272.79 /

-0.16 (-0.06%)

JNJ Johnson & Johnson
$159.50 /

+1.08 (+0.68%)

BIIB Biogen
$272.79 /

-0.16 (-0.06%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:23
03/01/21
03/01
12:23
03/01/21
12:23
JNJ

Johnson & Johnson

$160.50 /

+2.08 (+1.31%)

, XOM

Exxon Mobil

$57.12 /

+2.74 (+5.04%)

, OTRK

Ontrak

$30.17 /

-28.96 (-48.98%)

, ATNX

Athenex

$5.78 /

-6.41 (-52.61%)

, GRPN

Groupon

$59.42 /

+16.18 (+37.42%)

, MORF

Morphic Holding

$74.48 /

+38.55 (+107.29%)

The major averages are…

ShowHide Related Items >><<
XOM Exxon Mobil
$57.12 /

+2.74 (+5.04%)

OTRK Ontrak
$30.17 /

-28.96 (-48.98%)

MORF Morphic Holding
$74.48 /

+38.55 (+107.29%)

JNJ Johnson & Johnson
$160.50 /

+2.08 (+1.31%)

GRPN Groupon
$59.42 /

+16.18 (+37.42%)

ATNX Athenex
$5.78 /

-6.41 (-52.61%)

JNJ Johnson & Johnson
$160.50 /

+2.08 (+1.31%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
XOM Exxon Mobil
$57.12 /

+2.74 (+5.04%)

02/26/21 Barclays
Exxon Mobil price target raised to $65 from $59 at Barclays
02/16/21 Credit Suisse
Exxon Mobil price target raised to $62 from $52 at Credit Suisse
02/08/21
Fly Intel: Top five analyst upgrades
02/08/21 Exane BNP Paribas
Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas
OTRK Ontrak
$30.17 /

-28.96 (-48.98%)

03/01/21 RBC Capital
RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna
03/01/21 RBC Capital
Ontrak downgraded to Sector Perform from Outperform at RBC Capital
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
01/04/21 B. Riley Securities
Ontrak price target raised to $110 from $100 at B. Riley Securities
ATNX Athenex
$5.78 /

-6.41 (-52.61%)

02/10/21
Fly Intel: Top five analyst initiations
02/10/21 Evercore ISI
Athenex initiated with an Outperform at Evercore ISI
10/26/20
Fly Intel: Top five analyst initiations
10/26/20 SVB Leerink
Athenex initiated with an Outperform at SVB Leerink
GRPN Groupon
$59.42 /

+16.18 (+37.42%)

03/01/21 JPMorgan
JPMorgan upgrades Groupon to Neutral on new marketplace strategy
03/01/21 JPMorgan
Groupon upgraded to Neutral from Underweight at JPMorgan
01/04/21 Barclays
Groupon assumed with an Underweight at Barclays
11/02/20 Wedbush
Groupon price target lowered to $21 from $27 at Wedbush
MORF Morphic Holding
$74.48 /

+38.55 (+107.29%)

02/02/21 RBC Capital
Morphic Holding price target raised to $50 from $35 at RBC Capital
10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
08/11/20 BMO Capital
Morphic Holding price target raised to $37 from $30 at BMO Capital
XOM Exxon Mobil
$57.12 /

+2.74 (+5.04%)

OTRK Ontrak
$30.17 /

-28.96 (-48.98%)

MORF Morphic Holding
$74.48 /

+38.55 (+107.29%)

JNJ Johnson & Johnson
$160.50 /

+2.08 (+1.31%)

GRPN Groupon
$59.42 /

+16.18 (+37.42%)

ATNX Athenex
$5.78 /

-6.41 (-52.61%)

  • 10
    Sep
XOM Exxon Mobil
$57.12 /

+2.74 (+5.04%)

JNJ Johnson & Johnson
$160.50 /

+2.08 (+1.31%)

XOM Exxon Mobil
$57.12 /

+2.74 (+5.04%)

OTRK Ontrak
$30.17 /

-28.96 (-48.98%)

JNJ Johnson & Johnson
$160.50 /

+2.08 (+1.31%)

GRPN Groupon
$59.42 /

+16.18 (+37.42%)

ATNX Athenex
$5.78 /

-6.41 (-52.61%)

XOM Exxon Mobil
$57.12 /

+2.74 (+5.04%)

OTRK Ontrak
$30.17 /

-28.96 (-48.98%)

JNJ Johnson & Johnson
$160.50 /

+2.08 (+1.31%)

GRPN Groupon
$59.42 /

+16.18 (+37.42%)

Options
Unusually active option classes on open March 1st » 09:40
03/01/21
03/01
09:40
03/01/21
09:40
RCL

Royal Caribbean

$93.43 /

+ (+0.00%)

, NRG

NRG Energy

$36.50 /

+ (+0.00%)

, JNJ

Johnson & Johnson

$158.52 /

+0.1 (+0.06%)

, PBR

Petrobras

$7.92 /

+ (+0.00%)

, XOM

Exxon Mobil

$54.38 /

+ (+0.00%)

, RKT

Rocket Companies

$21.84 /

+ (+0.00%)

, C

Citi

$65.86 /

+ (+0.00%)

, BA

Boeing

$212.02 /

+ (+0.00%)

, WMT

Walmart

$129.87 /

-0.02 (-0.02%)

, PENN

Penn National

$115.83 /

+0.02 (+0.02%)

Unusual total active…

Unusual total active option classes on open include: Royal Caribbean (RCL), NRG Energy (NRG), Johnson & Johnson (JNJ), Petrobras (PBR), Exxon Mobil (XOM), Rocket Companies (RKT), Citi (C), Boeing (BA), Wal-Mart (WMT), and Penn National (PENN).

ShowHide Related Items >><<
XOM Exxon Mobil
$54.38 /

+ (+0.00%)

WMT Walmart
$129.87 /

-0.02 (-0.02%)

RKT Rocket Companies
$21.84 /

+ (+0.00%)

RCL Royal Caribbean
$93.43 /

+ (+0.00%)

PENN Penn National
$115.83 /

+0.02 (+0.02%)

PBR Petrobras
$7.92 /

+ (+0.00%)

NRG NRG Energy
$36.50 /

+ (+0.00%)

JNJ Johnson & Johnson
$158.52 /

+0.1 (+0.06%)

C Citi
$65.86 /

+ (+0.00%)

BA Boeing
$212.02 /

+ (+0.00%)

RCL Royal Caribbean
$93.43 /

+ (+0.00%)

02/24/21 Credit Suisse
Royal Caribbean price target raised to $117 from $76 at Credit Suisse
02/23/21 JPMorgan
Royal Caribbean price target raised to $100 from $91 at JPMorgan
02/23/21 Deutsche Bank
Royal Caribbean price target raised to $79 from $62 at Deutsche Bank
02/12/21 Berenberg
Royal Caribbean downgraded to Sell from Hold at Berenberg
NRG NRG Energy
$36.50 /

+ (+0.00%)

02/04/21
Fly Intel: Top five analyst initiations
02/04/21 Citi
NRG Energy resumed with a Buy at Citi
01/28/21 Goldman Sachs
NRG Energy reinstated with a Buy at Goldman Sachs
01/11/21 BofA
BofA US 1 List changes
JNJ Johnson & Johnson
$158.52 /

+0.1 (+0.06%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
PBR Petrobras
$7.92 /

+ (+0.00%)

02/22/21
Fly Intel: Top five analyst downgrades
02/22/21 Scotiabank
Scotiabank downgrades Petrobras on rising fuel price tension
02/22/21 BofA
Petrobras double-downgraded to Underperform from Buy at BofA
02/22/21 BofA
Petrobras downgraded to Underperform from Buy at BofA
XOM Exxon Mobil
$54.38 /

+ (+0.00%)

02/26/21 Barclays
Exxon Mobil price target raised to $65 from $59 at Barclays
02/16/21 Credit Suisse
Exxon Mobil price target raised to $62 from $52 at Credit Suisse
02/08/21
Fly Intel: Top five analyst upgrades
02/08/21 Exane BNP Paribas
Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas
RKT Rocket Companies
$21.84 /

+ (+0.00%)

01/19/21 JPMorgan
JPMorgan double downgrades Rocket on more cautious mortgage stance
01/19/21 JPMorgan
Rocket Companies downgraded to Underweight from Overweight at JPMorgan
12/17/20 Keefe Bruyette
Rocket Companies downgraded to Underperform at Keefe Bruyette
12/14/20
Fly Intel: Top five analyst initiations
C Citi
$65.86 /

+ (+0.00%)

03/01/21 Wells Fargo
Citi price target raised to $82 from $74 at Wells Fargo
01/21/21 Berenberg
Berenberg downgrades Citi to Hold after 50% rally
01/21/21 Berenberg
Citi downgraded to Hold from Buy at Berenberg
01/19/21 DA Davidson
Citi price target raised to $84 from $77 at DA Davidson
BA Boeing
$212.02 /

+ (+0.00%)

03/01/21 Morgan Stanley
Boeing price target raised to $250 from $230 at Morgan Stanley
02/19/21 Benchmark
Boeing price target lowered to $270 from $290 at Benchmark
02/10/21 Deutsche Bank
Airbus initiated with a Buy at Deutsche Bank
01/29/21
Fly Intel: Top five analyst upgrades Spire
WMT Walmart
$129.87 /

-0.02 (-0.02%)

02/23/21 Evercore ISI
Walmart accelerating change with investments, says Evercore ISI
02/19/21 Morgan Stanley
Walmart terminal value rising with investments, says Morgan Stanley
02/19/21 Cowen
Walmart weakness a buying opportunity, says Cowen
02/19/21 Deutsche Bank
Walmart price target lowered to $166 from $170 at Deutsche Bank
PENN Penn National
$115.83 /

+0.02 (+0.02%)

02/23/21 JPMorgan
JPMorgan ups Penn National target, says don't wait for selloff to buy
02/22/21 Craig-Hallum
Craig-Hallum reiterates $150 target on Penn National after Rush deal
02/09/21 Morgan Stanley
Morgan Stanley says legalized sports betting in Texas this year has 'slim' odds
02/05/21 Truist
Penn National price target raised to $135 from $120 at Truist
XOM Exxon Mobil
$54.38 /

+ (+0.00%)

WMT Walmart
$129.87 /

-0.02 (-0.02%)

RKT Rocket Companies
$21.84 /

+ (+0.00%)

RCL Royal Caribbean
$93.43 /

+ (+0.00%)

PENN Penn National
$115.83 /

+0.02 (+0.02%)

NRG NRG Energy
$36.50 /

+ (+0.00%)

JNJ Johnson & Johnson
$158.52 /

+0.1 (+0.06%)

C Citi
$65.86 /

+ (+0.00%)

BA Boeing
$212.02 /

+ (+0.00%)

  • 01
    Mar
  • 14
    Oct
  • 25
    Sep
  • 06
    Aug
  • 12
    May
XOM Exxon Mobil
$54.38 /

+ (+0.00%)

WMT Walmart
$129.87 /

-0.02 (-0.02%)

RKT Rocket Companies
$21.84 /

+ (+0.00%)

RCL Royal Caribbean
$93.43 /

+ (+0.00%)

PENN Penn National
$115.83 /

+0.02 (+0.02%)

PBR Petrobras
$7.92 /

+ (+0.00%)

JNJ Johnson & Johnson
$158.52 /

+0.1 (+0.06%)

C Citi
$65.86 /

+ (+0.00%)

BA Boeing
$212.02 /

+ (+0.00%)

XOM Exxon Mobil
$54.38 /

+ (+0.00%)

WMT Walmart
$129.87 /

-0.02 (-0.02%)

RKT Rocket Companies
$21.84 /

+ (+0.00%)

RCL Royal Caribbean
$93.43 /

+ (+0.00%)

PENN Penn National
$115.83 /

+0.02 (+0.02%)

NRG NRG Energy
$36.50 /

+ (+0.00%)

JNJ Johnson & Johnson
$158.52 /

+0.1 (+0.06%)

C Citi
$65.86 /

+ (+0.00%)

BA Boeing
$212.02 /

+ (+0.00%)

XOM Exxon Mobil
$54.38 /

+ (+0.00%)

WMT Walmart
$129.87 /

-0.02 (-0.02%)

RKT Rocket Companies
$21.84 /

+ (+0.00%)

RCL Royal Caribbean
$93.43 /

+ (+0.00%)

PENN Penn National
$115.83 /

+0.02 (+0.02%)

PBR Petrobras
$7.92 /

+ (+0.00%)

NRG NRG Energy
$36.50 /

+ (+0.00%)

JNJ Johnson & Johnson
$158.52 /

+0.1 (+0.06%)

C Citi
$65.86 /

+ (+0.00%)

BA Boeing
$212.02 /

+ (+0.00%)

On The Fly
Fly Intel: Pre-market Movers » 09:15
03/01/21
03/01
09:15
03/01/21
09:15
JNJ

Johnson & Johnson

$158.52 /

-4.28 (-2.63%)

, XOM

Exxon Mobil

$54.38 /

-1.37 (-2.46%)

, XRAY

Dentsply Sirona

$53.11 /

+0.64 (+1.22%)

, PRGO

Perrigo

$40.20 /

-0.58 (-1.42%)

, NRG

NRG Energy

$36.50 /

-1.06 (-2.82%)

, SSYS

Stratasys

$34.48 /

+0.29 (+0.85%)

, LOGI

Logitech

$108.00 /

+2.23 (+2.11%)

, ATNX

Athenex

$12.18 /

+0.29 (+2.44%)

, CEO

Cnooc

$118.84 /

-8.41 (-6.61%)

, VACQ

Vector Acquisition

$10.27 /

-0.01 (-0.10%)

Check out this morning's…

ShowHide Related Items >><<
XRAY Dentsply Sirona
$53.11 /

+0.64 (+1.22%)

XOM Exxon Mobil
$54.38 /

-1.37 (-2.46%)

VACQ Vector Acquisition
$10.27 /

-0.01 (-0.10%)

SSYS Stratasys
$34.48 /

+0.29 (+0.85%)

PRGO Perrigo
$40.20 /

-0.58 (-1.42%)

NRG NRG Energy
$36.50 /

-1.06 (-2.82%)

LOGI Logitech
$108.00 /

+2.23 (+2.11%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

CEO Cnooc
$118.84 /

-8.41 (-6.61%)

ATNX Athenex
$12.18 /

+0.29 (+2.44%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
XOM Exxon Mobil
$54.38 /

-1.37 (-2.46%)

02/26/21 Barclays
Exxon Mobil price target raised to $65 from $59 at Barclays
02/16/21 Credit Suisse
Exxon Mobil price target raised to $62 from $52 at Credit Suisse
02/08/21
Fly Intel: Top five analyst upgrades
02/08/21 Exane BNP Paribas
Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas
XRAY Dentsply Sirona
$53.11 /

+0.64 (+1.22%)

02/09/21 Stifel
Dentsply Sirona checks point to potential channel conflict, says Stifel
01/08/21 Credit Suisse
Envista upgraded to Outperform from Neutral at Credit Suisse
01/05/21 Baird
Dentsply Sirona price target raised to $62 from $58 at Baird
01/05/21 Barclays
Dentsply Sirona price target raised to $44 from $40 at Barclays
PRGO Perrigo
$40.20 /

-0.58 (-1.42%)

01/06/21 RBC Capital
Perrigo downgraded to Sector Perform from Outperform at RBC Capital
01/06/21 RBC Capital
Perrigo downgraded to Sector Perform from Outperform at RBC Capital
10/19/20 Morgan Stanley
Morgan Stanley sees volatility in Perrigo on Irish tax litigation ruling
06/16/20 JPMorgan
Perrigo tax dispute well reflected in shares, says JPMorgan
NRG NRG Energy
$36.50 /

-1.06 (-2.82%)

02/04/21
Fly Intel: Top five analyst initiations
02/04/21 Citi
NRG Energy resumed with a Buy at Citi
01/28/21 Goldman Sachs
NRG Energy reinstated with a Buy at Goldman Sachs
01/11/21 BofA
BofA US 1 List changes
SSYS Stratasys
$34.48 /

+0.29 (+0.85%)

01/19/21 Stifel
Stratasys initiated with a Buy at Stifel
01/15/21 JPMorgan
Stratasys downgraded to Underweight from Neutral at JPMorgan
10/09/20 Berenberg
Stratasys initiated with a Buy at Berenberg
09/24/20
Fly Intel: Top five analyst downgrades
LOGI Logitech
$108.00 /

+2.23 (+2.11%)

02/22/21 UBS
Logitech price target raised to CHF 108 from CHF 90 at UBS
02/10/21 DA Davidson
Corsair Gaming price target raised to $52 from $33 at DA Davidson
01/21/21 UBS
Logitech price target raised to CHF 90 from CHF 74 at UBS
01/20/21 Citi
Logitech price target raised to $130 from $110 at Citi
ATNX Athenex
$12.18 /

+0.29 (+2.44%)

02/10/21
Fly Intel: Top five analyst initiations
02/10/21 Evercore ISI
Athenex initiated with an Outperform at Evercore ISI
10/26/20
Fly Intel: Top five analyst initiations
10/26/20 SVB Leerink
Athenex initiated with an Outperform at SVB Leerink
CEO Cnooc
$118.84 /

-8.41 (-6.61%)

01/04/21 Bernstein
Cnooc upgraded to Outperform from Market Perform at Bernstein
12/01/20 Bernstein
Cnooc downgraded to Market Perform from Outperform at Bernstein
11/22/20 Goldman Sachs
Cnooc initiated with a Buy at Goldman Sachs
08/19/20 Credit Suisse
Cnooc upgraded to Outperform from Underperform at Credit Suisse
VACQ Vector Acquisition
$10.27 /

-0.01 (-0.10%)

XRAY Dentsply Sirona
$53.11 /

+0.64 (+1.22%)

XOM Exxon Mobil
$54.38 /

-1.37 (-2.46%)

SSYS Stratasys
$34.48 /

+0.29 (+0.85%)

PRGO Perrigo
$40.20 /

-0.58 (-1.42%)

NRG NRG Energy
$36.50 /

-1.06 (-2.82%)

LOGI Logitech
$108.00 /

+2.23 (+2.11%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

ATNX Athenex
$12.18 /

+0.29 (+2.44%)

  • 10
    Sep
XOM Exxon Mobil
$54.38 /

-1.37 (-2.46%)

VACQ Vector Acquisition
$10.27 /

-0.01 (-0.10%)

LOGI Logitech
$108.00 /

+2.23 (+2.11%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

XRAY Dentsply Sirona
$53.11 /

+0.64 (+1.22%)

XOM Exxon Mobil
$54.38 /

-1.37 (-2.46%)

VACQ Vector Acquisition
$10.27 /

-0.01 (-0.10%)

PRGO Perrigo
$40.20 /

-0.58 (-1.42%)

LOGI Logitech
$108.00 /

+2.23 (+2.11%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

ATNX Athenex
$12.18 /

+0.29 (+2.44%)

XRAY Dentsply Sirona
$53.11 /

+0.64 (+1.22%)

XOM Exxon Mobil
$54.38 /

-1.37 (-2.46%)

SSYS Stratasys
$34.48 /

+0.29 (+0.85%)

NRG NRG Energy
$36.50 /

-1.06 (-2.82%)

LOGI Logitech
$108.00 /

+2.23 (+2.11%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

Sunday
Hot Stocks
Fly Intel: Top five weekend stock stories » 20:03
02/28/21
02/28
20:03
02/28/21
20:03
JNJ

Johnson & Johnson

$158.52 /

-4.28 (-2.63%)

, BRK.B

Berkshire Hathaway

$240.27 /

-3.35 (-1.38%)

, BRK.A

Berkshire Hathaway

$364,420.00 /

-4355 (-1.18%)

, ROST

Ross Stores

$116.65 /

-2.08 (-1.75%)

, TWLO

Twilio

$392.84 /

+15.295 (+4.05%)

, CG

Carlyle Group

$34.24 /

-0.22 (-0.64%)

, AEP

American Electric

$74.88 /

-1.43 (-1.87%)

, D

Dominion

$68.29 /

-2.31 (-3.27%)

, ETR

Entergy

$86.82 /

-1.26 (-1.43%)

, EXC

Exelon

$38.60 /

-0.32 (-0.82%)

, NEE

NextEra Energy

$73.51 /

-0.55 (-0.74%)

, C

Citi

$65.86 /

-1.54 (-2.28%)

, DOW

Dow Inc.

$59.32 /

-2.055 (-3.35%)

, ASOMY

Asos

$0.00 /

+ (+0.00%)

Catch up on the…

Catch up on the weekend's top five stories with this list compiled by The Fly: 1. The Food and Drug Administration issued an emergency use authorization for the third vaccine for the prevention of coronavirus disease. The EUA allows Johnson & Johnson's (JNJ) Janssen COVID-19 vaccine to be distributed in the U.S for use in individuals 18 years of age and older. Meanwhile, Johnson & Johnson also announced that the U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices has recommended its single-shot COVID-19 vaccine. The ACIP recommendation will be forwarded to the Director of the CDC and the U.S. Department of Health and Human Services for review and adoption. Johnson & Johnson has begun shipping its COVID-19 vaccine and expects to deliver enough single-shot vaccines by the end of March to enable the full vaccination of more than 20M people in the U.S. The company plans to deliver 100M single-shot vaccines to the U.S. during the first half of 2021. The U.S. government will manage allocation and distribution of the vaccine in the U.S. 2. Warren Buffett Berkshire Hathaway's (BRK.A, BRK.B) fourth quarter profits rose, with its net earnings rising to $38.5B, or $23,015 a Class A share equivalent, up almost 23% from the previous year's profit of $29.2B, or $17,909 a share. Operating earnings, which exclude some investment results, rose to $5 billion from $4.4 billion the year before. Buffett also said in his annual shareholder letter to "never bet against America." "In its brief 232 years of existence... there has been no incubator for unleashing human potential like America," he added. "Despite some severe interruptions, our country's economic progress has been breathtaking. Our unwavering conclusion: Never bet against America." Buffett said the conglomerate owns the biggest amount of U.S. assets by value than any other company in the country. Berkshire Hathaway also bought back a record amount of company stock last year. During the fourth quarter, the company bought back about $9B shares for a total 2020 repurchase of $24.7B. Buffett said in his annual shareholder letter that repurchases have continued since year-end and "is likely to further reduce its share count in the future." 3. Ross Stores (ROST) offers shoppers a chance to find overlooked "treasures" among a heap of discards and its stock could offer investors the same opportunity, Teresa Rivas wrote in this week's edition of Barron's. The company has had a tough time during the pandemic and its stock has took a bigger beating, the author noted. But the underperformance means that Ross also has the most to gain as more vaccines are given and reopening accelerates, Rivas added. 4. Twilio (TWLO) is in talks to invest as much as $750M in Carlyle Group's (CG) Syniverse Technologies in a precursor to a public listing, Cara Lombardo and Dana Cimilluca of Wall Street Journal reported, citing people familiar with the matter. The investment will be announced Monday and could be followed in the coming months by a merger between Syniverse and a special-purpose acquisition company, sources told the Journal. Such a deal could value Syniverse around $2B to $3B including debt, they added. The Twilio deal involves a commercial arrangement that would send a significant amount of business to Syniverse, which provides roaming, messaging and other telecommunications services, the sources said. 5. American Electric Power (AEP), Dominion Energy (D), Entergy (ETR), Exelon (EXC), NextEra Energy (NEE), Citigroup (C), Dow (DOW) and Asos (ASOMY) saw positive mentions in this week's edition of Barron's.

ShowHide Related Items >><<
TWLO Twilio
$392.84 /

+15.295 (+4.05%)

ROST Ross Stores
$116.65 /

-2.08 (-1.75%)

NEE NextEra Energy
$73.51 /

-0.55 (-0.74%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

EXC Exelon
$38.60 /

-0.32 (-0.82%)

ETR Entergy
$86.82 /

-1.26 (-1.43%)

DOW Dow Inc.
$59.32 /

-2.055 (-3.35%)

D Dominion
$68.29 /

-2.31 (-3.27%)

CG Carlyle Group
$34.24 /

-0.22 (-0.64%)

C Citi
$65.86 /

-1.54 (-2.28%)

BRK.B Berkshire Hathaway
$240.27 /

-3.35 (-1.38%)

BRK.A Berkshire Hathaway
$364,420.00 /

-4355 (-1.18%)

AEP American Electric
$74.88 /

-1.43 (-1.87%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
BRK.B Berkshire Hathaway
$240.27 /

-3.35 (-1.38%)

07/07/20 Argus
Dominion price target lowered to $80 from $87 at Argus
BRK.A Berkshire Hathaway
$364,420.00 /

-4355 (-1.18%)

07/06/20 Guggenheim
Guggenheim 'loves' Dominion gas transmission sale, decision to scrap pipeline
04/06/20 Citi
Delta not 'broken story' but share weakness may persist, says Citi
ROST Ross Stores
$116.65 /

-2.08 (-1.75%)

01/21/21 Deutsche Bank
Ross Stores price target raised to $129 from $123 at Deutsche Bank
01/04/21 JPMorgan
Ross Stores price target raised to $128 from $125 at JPMorgan
11/20/20 MKM Partners
Ross Stores price target raised to $124 from $105 at MKM Partners
11/20/20 Loop Capital
Ross Stores price target raised to $130 from $110 at Loop Capital
TWLO Twilio
$392.84 /

+15.295 (+4.05%)

02/18/21 Northland
Twilio price target raised to $500 from $390 at Northland
02/18/21 Needham
Twilio price target raised to $500 from $340 at Needham
02/18/21 KeyBanc
Twilio price target raised to $550 from $420 at KeyBanc
02/18/21 Wells Fargo
Twilio price target raised to $525 from $450 at Wells Fargo
CG Carlyle Group
$34.24 /

-0.22 (-0.64%)

02/24/21 Deutsche Bank
Carlyle Group price target raised to $39 from $37 at Deutsche Bank
02/24/21 Barclays
Carlyle Group price target raised to $39 from $36 at Barclays
02/19/21
Fly Intel: Top five analyst upgrades
02/19/21 Credit Suisse
Carlyle Group upgraded to Outperform from Neutral at Credit Suisse
AEP American Electric
$74.88 /

-1.43 (-1.87%)

01/20/21 Guggenheim
American Electric upgraded to Buy from Neutral at Guggenheim
01/14/21 Goldman Sachs
American Electric downgraded to Sell from Neutral at Goldman Sachs
01/12/21
Fly Intel: Top five analyst downgrades
01/12/21 KeyBanc
American Electric downgraded to Sector Weight at KeyBanc
D Dominion
$68.29 /

-2.31 (-3.27%)

01/29/21 Mizuho
Dominion price target raised to $76 from $75 at Mizuho
01/26/21
Fly Intel: Top five analyst upgrades
01/26/21 Wells Fargo
Dominion upgraded to Overweight from Equal Weight at Wells Fargo
01/21/21 Evercore ISI
Dominion upgraded to Outperform from In Line at Evercore ISI
ETR Entergy
$86.82 /

-1.26 (-1.43%)

01/27/21 Mizuho
Entergy price target lowered to $105 from $110 at Mizuho
01/21/21 Evercore ISI
Entergy upgraded to Outperform from In Line at Evercore ISI
11/17/20 Mizuho
Entergy price target raised to $119 from $109 at Mizuho
11/16/20 Wolfe Research
Entergy upgraded to Outperform from Peer Perform at Wolfe Research
EXC Exelon
$38.60 /

-0.32 (-0.82%)

01/06/21 BofA
Exelon upgraded to Buy from Neutral at BofA
12/15/20 BofA
Exelon upgraded to Neutral from Underperform at BofA
12/11/20 Argus
Exelon price target raised to $45 from $42 at Argus
10/26/20
Fly Intel: Top five analyst downgrades
NEE NextEra Energy
$73.51 /

-0.55 (-0.74%)

01/27/21 Credit Suisse
NextEra Energy price target raised to $87 from $77 at Credit Suisse
01/27/21 Wells Fargo
NextEra Energy price target raised to $100 from $85 at Wells Fargo
01/20/21 Credit Suisse
NextEra Energy Partners price target raised to $86 from $71 at Credit Suisse
01/11/21 Mizuho
NextEra Energy price target raised to $90 from $64 at Mizuho
C Citi
$65.86 /

-1.54 (-2.28%)

01/21/21 Berenberg
Berenberg downgrades Citi to Hold after 50% rally
01/21/21 Berenberg
Citi downgraded to Hold from Buy at Berenberg
01/19/21 DA Davidson
Citi price target raised to $84 from $77 at DA Davidson
01/19/21 RBC Capital
Citi price target raised to $73 from $66 at RBC Capital
DOW Dow Inc.
$59.32 /

-2.055 (-3.35%)

02/22/21 BofA
Dow Inc. upgraded to Neutral from Underperform at BofA
02/22/21 BofA
Dow Inc. upgraded to Neutral from Underperform at BofA
02/09/21 Jefferies
Dow Inc. price target raised to $70 from $68 at Jefferies
01/22/21 JPMorgan
Dow Inc. price target raised to $64 from $60 at JPMorgan
ASOMY Asos
$0.00 /

+ (+0.00%)

02/23/21 Grupo Santander
Asos downgraded to Underweight from Hold at Grupo Santander
02/22/21 Barclays
Asos price target raised to 5,750 GBp from 5,150 GBp at Barclays
02/22/21 RBC Capital
Asos price target raised to 7,500 GBp from 6,000 GBp at RBC Capital
02/11/21 Credit Suisse
Asos price target raised to 7,250 GBp from 6,650 GBp at Credit Suisse
TWLO Twilio
$392.84 /

+15.295 (+4.05%)

ROST Ross Stores
$116.65 /

-2.08 (-1.75%)

NEE NextEra Energy
$73.51 /

-0.55 (-0.74%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

EXC Exelon
$38.60 /

-0.32 (-0.82%)

ETR Entergy
$86.82 /

-1.26 (-1.43%)

DOW Dow Inc.
$59.32 /

-2.055 (-3.35%)

D Dominion
$68.29 /

-2.31 (-3.27%)

CG Carlyle Group
$34.24 /

-0.22 (-0.64%)

C Citi
$65.86 /

-1.54 (-2.28%)

BRK.B Berkshire Hathaway
$240.27 /

-3.35 (-1.38%)

BRK.A Berkshire Hathaway
$364,420.00 /

-4355 (-1.18%)

AEP American Electric
$74.88 /

-1.43 (-1.87%)

  • 19
    Feb
  • 07
    Aug
TWLO Twilio
$392.84 /

+15.295 (+4.05%)

ROST Ross Stores
$116.65 /

-2.08 (-1.75%)

NEE NextEra Energy
$73.51 /

-0.55 (-0.74%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

EXC Exelon
$38.60 /

-0.32 (-0.82%)

DOW Dow Inc.
$59.32 /

-2.055 (-3.35%)

D Dominion
$68.29 /

-2.31 (-3.27%)

CG Carlyle Group
$34.24 /

-0.22 (-0.64%)

C Citi
$65.86 /

-1.54 (-2.28%)

BRK.B Berkshire Hathaway
$240.27 /

-3.35 (-1.38%)

BRK.A Berkshire Hathaway
$364,420.00 /

-4355 (-1.18%)

ASOMY Asos
$0.00 /

+ (+0.00%)

AEP American Electric
$74.88 /

-1.43 (-1.87%)

TWLO Twilio
$392.84 /

+15.295 (+4.05%)

ROST Ross Stores
$116.65 /

-2.08 (-1.75%)

NEE NextEra Energy
$73.51 /

-0.55 (-0.74%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

EXC Exelon
$38.60 /

-0.32 (-0.82%)

DOW Dow Inc.
$59.32 /

-2.055 (-3.35%)

CG Carlyle Group
$34.24 /

-0.22 (-0.64%)

C Citi
$65.86 /

-1.54 (-2.28%)

BRK.B Berkshire Hathaway
$240.27 /

-3.35 (-1.38%)

BRK.A Berkshire Hathaway
$364,420.00 /

-4355 (-1.18%)

TWLO Twilio
$392.84 /

+15.295 (+4.05%)

ROST Ross Stores
$116.65 /

-2.08 (-1.75%)

NEE NextEra Energy
$73.51 /

-0.55 (-0.74%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

EXC Exelon
$38.60 /

-0.32 (-0.82%)

DOW Dow Inc.
$59.32 /

-2.055 (-3.35%)

CG Carlyle Group
$34.24 /

-0.22 (-0.64%)

C Citi
$65.86 /

-1.54 (-2.28%)

Hot Stocks
CDC Advisory Committee recommends J&J single-shot COVID vaccine for adults 18+ » 17:41
02/28/21
02/28
17:41
02/28/21
17:41
JNJ

Johnson & Johnson

$158.52 /

-4.28 (-2.63%)

Johnson & Johnson…

Johnson & Johnson announced that the U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices has recommended the first single-shot COVID-19 vaccine, developed by the Janssen Pharmaceutical of Johnson & Johnson, for individuals 18 years of age and older under the Emergency Use Authorization issued by the U.S. Food and Drug Administration. The ACIP recommendation will be forwarded to the Director of the CDC and the U.S. Department of Health and Human Services for review and adoption. The company's single-shot COVID-19 vaccine received EUA from the FDA on February 27, 2021. The terms of the EUA allow use of the vaccine while more data are gathered. The company plans to file for a Biologics License Application with the FDA later in 2021. Johnson & Johnson has begun shipping its COVID-19 vaccine and expects to deliver enough single-shot vaccines by the end of March to enable the full vaccination of more than 20M people in the U.S. The company plans to deliver 100M single-shot vaccines to the U.S. during the first half of 2021. The U.S. government will manage allocation and distribution of the vaccine in the U.S.

ShowHide Related Items >><<
JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

Saturday
Hot Stocks
Johnson & Johnson Covid vaccine granted emergency approval from FDA » 19:15
02/27/21
02/27
19:15
02/27/21
19:15
JNJ

Johnson & Johnson

$158.52 /

-4.28 (-2.63%)

The Food and Drug…

The Food and Drug Administration issued an emergency use authorization for the third vaccine for the prevention of coronavirus disease The EUA allows Johnson & Johnson's Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older. The FDA has determined that the Janssen COVID-19 Vaccine has met the statutory criteria for issuance of an EUA. The totality of the available data "provides clear evidence that the Janssen COVID-19 Vaccine may be effective in preventing COVID-19," the agency said in a statement. The data also show that the vaccine's known and potential benefits outweigh its known and potential risks, supporting the company's request for the vaccine's use in people 18 years of age and older. The Janssen COVID-19 Vaccine is manufactured using a specific type of virus called adenovirus type 26. The vaccine uses Ad26 to deliver a piece of the DNA, or genetic material, that is used to make the distinctive "spike" protein of the SARS-CoV-2 virus, the FDA said. While adenoviruses are a group of viruses that are relatively common, Ad26, which can cause cold symptoms and pink eye, has been modified for the vaccine so that it cannot replicate in the human body to cause illness, it added. After a person receives this vaccine, the body can temporarily make the spike protein, which does not cause disease, but triggers the immune system to learn to react defensively, producing an immune response against SARS-CoV-2.

ShowHide Related Items >><<
JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

Friday
Hot Stocks
J&J confirms FDA panel recommends COVID-19 vaccine for EUA » 17:45
02/26/21
02/26
17:45
02/26/21
17:45
JNJ

Johnson & Johnson

$158.52 /

-4.28 (-2.63%)

Johnson & Johnson…

Johnson & Johnson announced that the U.S. Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee unanimously voted to recommend Emergency Use Authorization for the company's single-shot COVID-19 vaccine candidate for adults 18 and older, developed by the Janssen Pharmaceutical companies of Johnson & Johnson. The vote was based on a totality of scientific evidence provided by the Company, including efficacy and safety data from the Phase 3 ENSEMBLE trial. "We are extremely grateful to the VRBPAC members for their extensive review of the data supporting emergency use of Johnson & Johnson's single-shot COVID-19 vaccine candidate," said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson. "We believe our COVID-19 vaccine candidate has the potential to help change the trajectory of the pandemic and stand ready to make it available to protect the public as soon as possible." The next step in the process is for the FDA to decide whether to grant an EUA for Janssen's COVID-19 vaccine candidate. The recommendation of the FDA Advisory Committee is non-binding, and the final decision on authorization is made by the FDA. Under an EUA, the FDA has the authority to allow unapproved medical products or unapproved uses of approved medical products to be used in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions during a declared public health emergency. If authorized by the FDA, the U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices will then provide a recommendation on the use and roll-out of the Janssen COVID-19 vaccine candidate.

ShowHide Related Items >><<
JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

Periodicals
FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says » 17:06
02/26/21
02/26
17:06
02/26/21
17:06
JNJ

Johnson & Johnson

$158.52 /

-4.28 (-2.63%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

, SPY

SPDR S&P 500 ETF Trust

$380.35 /

-2.04 (-0.53%)

An FDA advisory panel has…

An FDA advisory panel has voted unanimously to say that the benefits of Johnson & Johnson's COVID-19 vaccine outweigh its risks for people 18 and older, CNBC's Meg Tirrell reports. The 22 members of the panel all voted yes, with nobody voting no and no abstentions, Tirrell says. Reference Link

ShowHide Related Items >><<
SPY SPDR S&P 500 ETF Trust
$380.35 /

-2.04 (-0.53%)

SPX S&P 500
$0.00 /

+ (+0.00%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
SPX S&P 500
$0.00 /

+ (+0.00%)

01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
SPY SPDR S&P 500 ETF Trust
$380.35 /

-2.04 (-0.53%)

SPX S&P 500
$0.00 /

+ (+0.00%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

SPX S&P 500
$0.00 /

+ (+0.00%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

SPY SPDR S&P 500 ETF Trust
$380.35 /

-2.04 (-0.53%)

SPX S&P 500
$0.00 /

+ (+0.00%)

JNJ Johnson & Johnson
$158.52 /

-4.28 (-2.63%)

SPY SPDR S&P 500 ETF Trust
$380.35 /

-2.04 (-0.53%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.